chr3-169085028-G-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_004991.4(MECOM):c.3601C>A(p.Leu1201Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000743 in 1,614,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004991.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000918 AC: 23AN: 250430Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135426
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1461738Hom.: 0 Cov.: 30 AF XY: 0.0000358 AC XY: 26AN XY: 727180
GnomAD4 genome AF: 0.000368 AC: 56AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74486
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The p.L1201M variant (also known as c.3601C>A), located in coding exon 17 of the MECOM gene, results from a C to A substitution at nucleotide position 3601. The leucine at codon 1201 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at